돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 41314생성일: 2026년 10월 23일

Water → (2S)-2-methyl-1-[(2-methyl-4-pyridinyl)carbonyl]-4-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine formic acid salt

https://huagongshe.com/ko/reaction/41314

반응식

참여 물질

역할이름HCID투입량
반응물WaterHCID 962—
반응물1-HydroxybenzotriazoleHCID 75771—
반응물DiisopropylethylamineHCID 81531—
반응물Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 2733084—
반응물2-Methylpyridine-4-carboxylic acidHCID 2762821—
반응물(S)-3-Methyl-1-((4-(trifluoromethyl)phenyl)sulfonyl)piperazineHCID 59152086—
용매DimethylformamideHCID 6228—
생성물(2S)-2-methyl-1-[(2-methyl-4-pyridinyl)carbonyl]-4-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine formic acid saltHCID 44612081120.7%

반응 단계

To a solution of (3S)-3-methyl-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine (Description 2) (80 mg, 0.259 mmol) in DMF (5 ml) was added 2-methyl-4-pyridinecarboxylic acid (35.6 mg, 0.259 mmol), HOBT.H2O (39.7 mg, 0.259 mmol), HBTU (98 mg, 0.259 mmol) and DIPEA (0.136 ml, 0.778 mmol) and the reaction mixture was stirred at room temperature overnight. DMF was evaporated in vacuo then DCM (5 ml) was added and washed with saturated aq. NaHCO3 solution (5 ml), dried on a phase separation cartridge and evaporated in vacuo. The crude material was dissolved in MeCN/DMSO 1:1 and purified by MDAP. The desired fractions were collected and concentrated in vacuo giving the title compound (74 mg).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08530478B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-43d2502aae1d4b49bf668f12fc6946c8
출처 메모uspto-grants-2013_09